Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.050
-0.110 (-2.64%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $150.03 million as of August 6, 2026. Its market cap has increased by 10.76% in one year.
Market Cap
150.03M
Enterprise Value
57.21M
1-Year Change
10.76%
Ranking
Category
Stock Price
$4.05
ChartMarket Cap Chart
Since the IPO on June 16, 2021, Molecular Partners AG's market cap has decreased from $683.35M to $150.03M, a decrease of -78.05%. That is a compound annual growth rate of -25.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 150.03M | -6.31% |
| Dec 30, 2025 | 160.13M | -2.96% |
| Dec 30, 2024 | 165.01M | 22.94% |
| Dec 29, 2023 | 134.22M | -38.09% |
| Dec 30, 2022 | 216.81M | -65.56% |
| Dec 30, 2021 | 629.47M | -7.89% |
| Jun 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aardvark Therapeutics | 164.60M |
| LENZ Therapeutics | 163.98M |
| Caribou Biosciences | 161.17M |
| YD Bio | 159.63M |
| Nkarta | 158.12M |
| Milestone Pharmaceuticals | 155.78M |
| Indaptus Therapeutics | 155.14M |
| Cibus | 148.08M |